{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:02:53Z","timestamp":1768006973027,"version":"3.49.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Research"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.envres.2022.113282","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T12:11:37Z","timestamp":1650975097000},"page":"113282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"PC","title":["RP-HPLC Method Development, Validation, and Drug Repurposing of Sofosbuvir Pharmaceutical Dosage Form: A Multidimensional Study"],"prefix":"10.1016","volume":"212","author":[{"given":"Ghulam Rasool","family":"Mangrio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apichit","family":"Maneengam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunera","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tassadaq Hussain","family":"Jafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghulam Qadir","family":"Chanihoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayan","family":"Nassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8533-0855","authenticated-orcid":false,"given":"Ahsanullah","family":"Unar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.envres.2022.113282_bib1","first-page":"183","article-title":"QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase II\u03b1","volume":"8","author":"Alam","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"issue":"7","key":"10.1016\/j.envres.2022.113282_bib2","doi-asserted-by":"crossref","first-page":"101303","DOI":"10.1016\/j.isci.2020.101303","article-title":"Current status of COVID-19 therapies and drug repositioning applications","volume":"23","author":"Altay","year":"2020","journal-title":"iScience"},{"issue":"6223","key":"10.1016\/j.envres.2022.113282_bib3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.1259210","article-title":"Structural basis for RNA replication by the hepatitis C virus polymerase","volume":"347","author":"Appleby","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.envres.2022.113282_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3851\/IMP3061","article-title":"Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials","volume":"22","author":"Arias","year":"2017","journal-title":"Antivir. Ther."},{"issue":"8","key":"10.1016\/j.envres.2022.113282_bib5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"W1","key":"10.1016\/j.envres.2022.113282_bib7","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"29","key":"10.1016\/j.envres.2022.113282_bib76","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1021\/jp302103t","article-title":"A comparison of multiscale methods for the analysis of molecular dynamics simulations","volume":"116","author":"Benson","year":"2012","journal-title":"J. Phys. Chem. B."},{"key":"10.1016\/j.envres.2022.113282_bib8","first-page":"1","article-title":"Novel corona virus (COVID-19) pandemic: current status and possible strategies for detection and treatment of the disease","author":"Bhagat","year":"2020","journal-title":"Expert Rev. Anti-infect. Ther."},{"key":"10.1016\/j.envres.2022.113282_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.684020","article-title":"Bioactive molecules of Tea as potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2","volume":"8","author":"Bhardwaj","year":"2021","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO;2-X","article-title":"Soft drug design: general principles and recent applications","volume":"20","author":"Bodor","year":"2000","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.envres.2022.113282_bib11","series-title":"Q2(R1) Validation of Analytical Procedures","first-page":"127","author":"Borman","year":"2017"},{"issue":"4","key":"10.1016\/j.envres.2022.113282_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/1567201043334542","article-title":"Drug delivery across the blood-brain barrier","volume":"1","author":"Chen","year":"2004","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.envres.2022.113282_bib13","series-title":"admetSAR: a Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties","author":"Cheng","year":"2012"},{"issue":"4","key":"10.1016\/j.envres.2022.113282_bib14","first-page":"331","article-title":"Sofosbuvir: a novel oral agent for chronic hepatitis C","volume":"27","author":"Cholongitas","year":"2014","journal-title":"Ann. Gastroenterol.: Q. Publ. Hellenic Soc. Gastroenterol."},{"issue":"6","key":"10.1016\/j.envres.2022.113282_bib15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.drudis.2020.04.005","article-title":"Boosting the arsenal against COVID-19 through computational drug repurposing","volume":"25","author":"Ciliberto","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib16","first-page":"1","article-title":"Clinical decision support tools: analysis of online drug information databases","volume":"7","author":"Clauson","year":"2007","journal-title":"BMC Med. Inf. Decis. Making"},{"key":"10.1016\/j.envres.2022.113282_bib17","series-title":"ChemDraw Ultra 9.0. CambridgeSoft, 100 CambridgePark Drive","author":"Cousins","year":"2005"},{"issue":"W1","key":"10.1016\/j.envres.2022.113282_bib18","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.envres.2022.113282_bib19","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jhep.2019.07.020","article-title":"Real-life effectiveness and safety of sofosbuvir\/velpatasvir\/voxilaprevir in hepatitis C patients with previous DAA failure","volume":"71","author":"Degasperi","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/hep.27375","article-title":"Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir","volume":"61","author":"Donaldson","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.envres.2022.113282_bib21","doi-asserted-by":"crossref","first-page":"104708","DOI":"10.1016\/j.antiviral.2020.104708","article-title":"Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro","volume":"175","author":"Dragoni","year":"2020","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.envres.2022.113282_bib22","first-page":"114","article-title":"Validated ultraviolet-spectrometric method for determination of sofosbuvir in tablets formulation","volume":"7","author":"El Hamd","year":"2017","journal-title":"J. Appl. Pharmaceut. Sci."},{"issue":"11","key":"10.1016\/j.envres.2022.113282_bib23","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jproteome.0c00779","article-title":"Molecular basis of SARS-CoV-2 infection and rational design of potential antiviral agents: modeling and simulation approaches","volume":"19","author":"Frances-Monerris","year":"2020","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s43588-020-00007-6","article-title":"Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies","volume":"1","author":"Galindez","year":"2021","journal-title":"Nat. Comput. Sci."},{"issue":"2","key":"10.1016\/j.envres.2022.113282_bib25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/cbdd.13091","article-title":"Sofosbuvir as treatment against dengue?","volume":"91","author":"Gan","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.envres.2022.113282_bib26","first-page":"47","article-title":"Identification of novel protein sequencing SARS CoV-2 coronavirus using machine learning","author":"Ghulam","year":"2021","journal-title":"Biosci. Res."},{"issue":"27","key":"10.1016\/j.envres.2022.113282_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh3032","article-title":"Identification of SARS-CoV-2\u2013induced pathways reveals drug repurposing strategies","volume":"7","author":"Han","year":"2021","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.envres.2022.113282_bib28","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1021\/ci7002076","article-title":"ADME evaluation in drug discovery. 8. The prediction of human intestinal absorption by a support vector machine","volume":"47","author":"Hou","year":"2007","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-021-01837-y","article-title":"Sofosbuvir\/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan","volume":"21","author":"Huang","year":"2021","journal-title":"BMC Gastroenterol."},{"issue":"4","key":"10.1016\/j.envres.2022.113282_bib30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/clpt.2013.1","article-title":"Computational drug repositioning: from data to therapeutics","volume":"93","author":"Hurle","year":"2013","journal-title":"Clin. Pharmacol. Therapeut."},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-66440-9","article-title":"Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic","volume":"10","author":"J\u00e1come","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13321-020-00450-7","article-title":"A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions","volume":"12","author":"Jarada","year":"2020","journal-title":"J. Cheminf."},{"issue":"S2","key":"10.1016\/j.envres.2022.113282_bib33","first-page":"100","article-title":"Repurposing drugs for COVID-19: an approach for treatment in the pandemic","volume":"26","author":"Khadka","year":"2020","journal-title":"Alternative Ther. Health Med."},{"issue":"2","key":"10.1016\/j.envres.2022.113282_bib71","doi-asserted-by":"crossref","first-page":"565","DOI":"10.19045\/bspab.2018.70070","article-title":"20. Revealing potential drug targets against Proto-oncogene Wnt10B by comparative molecular docking","volume":"7","author":"Khalid","year":"2018","journal-title":"Pure Appl. Biol."},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib34","article-title":"http:\/\/Mcule. com: A public web service for drug discovery","volume":"4","author":"Kiss","year":"2012","journal-title":"J. Cheminf."},{"issue":"2","key":"10.1016\/j.envres.2022.113282_bib70","first-page":"145","article-title":"In silico identification of flavonoids from corriandrum sativum seeds against coronavirus covid-19 main","volume":"11","author":"Kumar","year":"2021","journal-title":"Protease"},{"key":"10.1016\/j.envres.2022.113282_bib35","series-title":"Biodegradable Polymers for Drug Delivery Systems","first-page":"83","author":"Kwon","year":"2007"},{"issue":"2","key":"10.1016\/j.envres.2022.113282_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"issue":"12","key":"10.1016\/j.envres.2022.113282_bib77","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1110\/ps.051681605","article-title":"A statistical approach to the interpretation of molecular dynamics simulations of calmodulin equilibrium dynamics","volume":"14","author":"Liki\u0107","year":"2005","journal-title":"Protein Sci."},{"issue":"2","key":"10.1016\/j.envres.2022.113282_bib75","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10822-016-0005-2","article-title":"Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations","volume":"31","author":"Liu","year":"2017","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"9","key":"10.1016\/j.envres.2022.113282_bib37","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/v12091058","article-title":"Drug repositioning: new approaches and future prospects for life-debilitating diseases and the COVID-19 pandemic outbreak","volume":"12","author":"Low","year":"2020","journal-title":"Viruses"},{"issue":"32","key":"10.1016\/j.envres.2022.113282_bib38","doi-asserted-by":"crossref","DOI":"10.2174\/1568026619666190121125106","article-title":"Combating diseases with computational strategies used for drug design and discovery","volume":"18","author":"Makhouri","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00162-20","article-title":"Remdesivir against COVID-19 and other viral diseases","volume":"34","author":"Malin","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib40","first-page":"1","article-title":"Blocking Zika virus vertical transmission","volume":"8","author":"Mesci","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.envres.2022.113282_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199941","article-title":"All-oral direct antiviral treatment for hepatitis C chronic infection in a real-life cohort: the role of cirrhosis and comorbidities in treatment response","volume":"13","author":"Miotto","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.envres.2022.113282_bib42","series-title":"Computer-aided Drug Repurposing for Cancer Therapy: Approaches and Opportunities to Challenge Anticancer Targets. Seminars in Cancer Biology","author":"Mottini","year":"2021"},{"issue":"6","key":"10.1016\/j.envres.2022.113282_bib43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/adt.2015.29011.tiodrrr","article-title":"Computational and practical aspects of drug repositioning","volume":"13","author":"Oprea","year":"2015","journal-title":"Assay Drug Dev. Technol."},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib44","doi-asserted-by":"crossref","first-page":"115094","DOI":"10.1016\/j.diagmicrobio.2020.115094","article-title":"Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review","volume":"98","author":"Ortiz-Prado","year":"2020","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.envres.2022.113282_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0022-3859.81870","article-title":"Drug repositioning: re-investigating existing drugs for new therapeutic indications","volume":"57","author":"Padhy","year":"2011","journal-title":"J. Postgrad. Med."},{"key":"10.1016\/j.envres.2022.113282_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-12-405880-4.00005-6","article-title":"Hepatitis C virus: standard-of-care treatment","volume":"67","author":"Pawlotsky","year":"2013","journal-title":"Adv. Pharmacol."},{"issue":"3","key":"10.1016\/j.envres.2022.113282_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s007920070028","article-title":"Xylanase from the psychrophilic yeast Cryptococcus adeliae","volume":"4","author":"Petrescu","year":"2000","journal-title":"Extremophiles"},{"issue":"13","key":"10.1016\/j.envres.2022.113282_bib48","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"5","key":"10.1016\/j.envres.2022.113282_bib49","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3390\/cells10051052","article-title":"Remdesivir and ledipasvir among the FDA-approved antiviral drugs have potential to inhibit SARS-CoV-2 replication","volume":"10","author":"Pirzada","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"119","key":"10.1016\/j.envres.2022.113282_bib51","doi-asserted-by":"crossref","first-page":"98269","DOI":"10.1039\/C5RA20233G","article-title":"Quantitative performance of online SPE-LC coupled to Q-Exactive for the analysis of sofosbuvir in human plasma","volume":"5","author":"Qu","year":"2015","journal-title":"RSC Adv."},{"issue":"10","key":"10.1016\/j.envres.2022.113282_bib52","first-page":"7","article-title":"A review on step-by-step analytical method validation","volume":"5","author":"Ravisankar","year":"2015","journal-title":"IOSR J. Pharm."},{"key":"10.1016\/j.envres.2022.113282_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jpba.2015.05.006","article-title":"Development of a sensitive UPLC-ESI-MS\/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: application to a bioequivalence study","volume":"114","author":"Rezk","year":"2015","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"12","key":"10.1016\/j.envres.2022.113282_bib54","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1128\/AAC.01693-15","article-title":"Validation and application of a liquid chromatography-tandem mass spectrometry method to determine the concentrations of sofosbuvir anabolites in cells","volume":"59","author":"Rower","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.envres.2022.113282_bib55","series-title":"Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications","article-title":"Drug Repurposing (DR): An Emerging Approach in Drug Discovery","author":"Rudrapal","year":"2020"},{"issue":"7","key":"10.1016\/j.envres.2022.113282_bib56","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00249-011-0700-9","article-title":"Definition and testing of the GROMOS force-field versions 54A7 and 54B7","volume":"40","author":"Schmid","year":"2011","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.envres.2022.113282_bib74","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/173521","article-title":"Relaxation estimation of RMSD in molecular dynamics immunosimulations","volume":"2012","author":"Schreiner","year":"2012","journal-title":"Comput. Math. Methods Med."},{"issue":"19","key":"10.1016\/j.envres.2022.113282_bib57","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1021\/jp984217f","article-title":"The GROMOS biomolecular simulation program package","volume":"103","author":"Scott","year":"1999","journal-title":"J. Phys. Chem."},{"issue":"24","key":"10.1016\/j.envres.2022.113282_bib58","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.2174\/1568026620666200710105507","article-title":"Therapeutic targets and computational approaches on drug development for COVID-19","volume":"20","author":"Shanmugam","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"issue":"6","key":"10.1016\/j.envres.2022.113282_bib59","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/14787210.2021.1851195","article-title":"Drug repurposing: new strategies for addressing COVID-19 outbreak","volume":"19","author":"Shende","year":"2021","journal-title":"Expert Rev. Anti-infect. Ther."},{"issue":"9","key":"10.1016\/j.envres.2022.113282_bib60","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.envres.2022.113282_bib61","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jchromb.2015.08.038","article-title":"Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC\u2013MS\/MS","volume":"1002","author":"Shi","year":"2015","journal-title":"J. Chromatogr. B"},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/23808993.2018.1424535","article-title":"Drug repositioning: current approaches and their implications in the precision medicine era","volume":"3","author":"Talevi","year":"2018","journal-title":"Exp. Rev. Precis. Med. Drug Dev."},{"key":"10.1016\/j.envres.2022.113282_bib63","first-page":"100553","article-title":"Evaluating new strategies for anticancer molecules from ethnic medicinal plants through in silico and biological approach-A review","volume":"18","author":"Vibala","year":"2020","journal-title":"Gen. Rep."},{"issue":"4","key":"10.1016\/j.envres.2022.113282_bib64","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/13543776.2021.1880568","article-title":"SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19","volume":"31","author":"Vicenti","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"issue":"5","key":"10.1016\/j.envres.2022.113282_bib65","first-page":"775","article-title":"Development and validation of new RP-HPLC method for the determination of sofosbuvir in pure form","volume":"5","author":"Vikas","year":"2016","journal-title":"World J. Pharm. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.envres.2022.113282_bib72","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/17460441.2012.648612","article-title":"Going further than Lipinski\u2019s rule in drug design","volume":"7","author":"Walters","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"issue":"6","key":"10.1016\/j.envres.2022.113282_bib66","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1021\/acs.jcim.0c00179","article-title":"Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study","volume":"60","author":"Wang","year":"2020","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib67","first-page":"1","article-title":"Evaluation of Sofosbuvir (\u03b2-D-2\u2032-deoxy-2\u2032-\u03b1-fluoro-2\u2032-\u03b2-C-methyluridine) as an inhibitor of Dengue virus replication","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.envres.2022.113282_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.envres.2022.113282_bib69","series-title":"Chemistry Software Package ChemOffice Ultra 2005","author":"Zielesny","year":"2005"}],"container-title":["Environmental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013935122006090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013935122006090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T20:58:29Z","timestamp":1757969909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013935122006090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":75,"alternative-id":["S0013935122006090"],"URL":"https:\/\/doi.org\/10.1016\/j.envres.2022.113282","relation":{},"ISSN":["0013-9351"],"issn-type":[{"value":"0013-9351","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RP-HPLC Method Development, Validation, and Drug Repurposing of Sofosbuvir Pharmaceutical Dosage Form: A Multidimensional Study","name":"articletitle","label":"Article Title"},{"value":"Environmental Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.envres.2022.113282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113282"}}